Protective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death : Biological Chemistry Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

249,00 € / $374.00 / £187.00*

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue
Loading journal volume and issue information...

30,00 € / $42.00 / £23.00

Get Access to Full Text

Protective Activity of Aromatic Amines and Imines against Oxidative Nerve Cell Death

Bernd Moosmann / Thomas Skutella / Klaus Beyer / Christian Behl

Citation Information: Biological Chemistry. Volume 382, Issue 11, Pages 1601–1612, ISSN (Print) 1431-6730, DOI: 10.1515/BC.2001.195, June 2005

Publication History

Published Online:
2005-06-01

Abstract

Oxidative stress is a widespread phenomenon in the pathology of neurodegenerative diseases such as Alzheimers disease, Parkinsons disease, and amyotrophic lateral sclerosis. Neuronal cell death due to oxidative stress may causally contribute to the pathogeneses of these diseases. Therefore, neuroprotective antioxidants are considered to be a promising approach to slow down disease progression. We have investigated different aromatic amine and imine compounds for neuroprotective antioxidant functions in cell culture, and found that these compounds possess excellent cytoprotective potential in diverse paradigms of oxidative neuronal cell death, including clonal cell lines, primary cerebellar neurons, and organotypic hippocampal slice cultures. Aromatic amines and imines are effective against oxidative glutamate toxicity, glutathione depletion, and hydrogen peroxide toxicity. Their mode of action as direct antioxidants was experimentally confirmed by electron spin resonance spectroscopy, cellfree brain lipid peroxidation assays, and intracellular peroxide measurements. With halfmaximal effective concentrations of 2075 nM in different neuroprotection experiments, the aromatic imines phenothiazine, phenoxazine, and iminostilbene proved to be about two orders of magnitude more effective than common phenolic antioxidants. This remarkable efficacy could be directly correlated to calculated properties of the compounds by means of a novel, quantitative structureactivity relationship model. We conclude that bridged bisarylimines with a single free NHbond, such as iminostilbene, are superior neuroprotective antioxidants, and may be promising lead structures for rational drug development.

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Dattatray Chadar, Soniya S. Rao, Ayesha Khan, Shridhar P. Gejji, Kiesar Sideeq Bhat, Thomas Weyhermüller, and Sunita Salunke-Gawali
RSC Adv., 2015, Volume 5, Number 71, Page 57917
[2]
Nicole Zimmermann, Jürgen Zschocke, Tatjana Perisic, Shuang Yu, Florian Holsboer, and Theo Rein
Biochemical Journal, 2012, Volume 448, Number 1, Page 93
[3]
Parvana Hajieva, Nadhim Bayatti, Matthias Granold, Christian Behl, and Bernd Moosmann
Journal of Neurochemistry, 2015, Volume 133, Number 3, Page 352
[4]
Matthias Granold, Bernd Moosmann, Irina Staib-Lasarzik, Thomas Arendt, Adriana del Rey, Kristin Engelhard, Christian Behl, and Parvana Hajieva
Redox Biology, 2015, Volume 4, Page 200
[5]
Phuriphong Songarj, Clara Luh, Irina Staib-Lasarzik, Kristin Engelhard, Bernd Moosmann, and Serge C. Thal
Neuroscience Letters, 2015, Volume 584, Page 253
[6]
F. Gonzalez-Lima, Bryan R. Barksdale, and Julio C. Rojas
Biochemical Pharmacology, 2014, Volume 88, Number 4, Page 584
[7]
S. Goodenough, D. Schleusner, C. Pietrzik, T. Skutella, and C. Behl
Neuroscience, 2005, Volume 132, Number 3, Page 581
[8]
Maike J. Ohlow, Matthias Granold, Mathias Schreckenberger, and Bernd Moosmann
FEBS Letters, 2012, Volume 586, Number 6, Page 711
[9]
Julio C. Rojas, Aleksandra K. Bruchey, and F. Gonzalez-Lima
Progress in Neurobiology, 2012, Volume 96, Number 1, Page 32
[10]
Parvana Hajieva, Christoph Kuhlmann, Heiko J. Luhmann, and Christian Behl
Neuroscience Letters, 2009, Volume 451, Number 2, Page 119
[11]
Penny D. Riha, Julio C. Rojas, and F. Gonzalez-Lima
NeuroImage, 2011, Volume 54, Number 4, Page 2623
[12]
J.C. Rojas, N. Simola, B.A. Kermath, J.R. Kane, T. Schallert, and F. Gonzalez-Lima
Neuroscience, 2009, Volume 163, Number 3, Page 877
[13]
Sharon Goodenough, Sabine Conrad, Thomas Skutella, and Christian Behl
Brain Research, 2004, Volume 1026, Number 1, Page 116
[14]
You-Zhi Tang and Zai-Qun Liu
Bioorganic & Medicinal Chemistry, 2007, Volume 15, Number 5, Page 1903
[15]
Andrzej B. Hendrich, Kamila Stańczak, Małgorzata Komorowska, Noboru Motohashi, Masami Kawase, and Krystyna Michalak
Bioorganic & Medicinal Chemistry, 2006, Volume 14, Number 17, Page 5948
[16]
Jürgen Zschocke, Nicole Zimmermann, Barbara Berning, Vanessa Ganal, Florian Holsboer, and Theo Rein
Neuropsychopharmacology, 2011, Volume 36, Number 8, Page 1754
[17]
Justyna B. Mocko, Andreas Kern, Bernd Moosmann, Christian Behl, and Parvana Hajieva
Neurobiology of Disease, 2010, Volume 40, Number 1, Page 120
[19]
[20]
Richard L. Kraus, Rodger Pasieczny, Karen Lariosa-Willingham, Mary S. Turner, Alice Jiang, and John W. Trauger
Journal of Neurochemistry, 2005, Volume 94, Number 3, Page 819
[21]
E. Yu. Shasheva, N. I. Vikrishchuk, L. D. Popov, A. D. Vikrishchuk, I. E. Mikhailov, K. A. Lysenko, and M. E. Kletskii
Russian Journal of General Chemistry, 2009, Volume 79, Number 10, Page 2234
[22]
Parvana Hajieva, Justyna B. Mocko, Bernd Moosmann, and Christian Behl
Journal of Neurochemistry, 2009, Volume 110, Number 1, Page 118
[23]
A. Bender, P. Hajieva, and B. Moosmann
Proceedings of the National Academy of Sciences, 2008, Volume 105, Number 43, Page 16496
[24]
Bernd Moosmann and Christian Behl
Expert Opinion on Investigational Drugs, 2002, Volume 11, Number 10, Page 1407
[25]
B. Vigante, G. Tirzitis, D. Tirzite, B. Chekavichus, J. Uldrikis, A. Sobolev, and G. Duburs
Chemistry of Heterocyclic Compounds, 2007, Volume 43, Number 2, Page 225
[26]
Xin Lin, Li-Ying Xue, Rui Wang, Qian-Yu Zhao, and Qiang Chen
FEBS Journal, 2006, Volume 273, Number 6, Page 1275

Comments (0)

Please log in or register to comment.